.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Dow
Baxter
McKinsey
Farmers Insurance
Daiichi Sankyo
Healthtrust
Express Scripts
Chinese Patent Office
Citi

Generated: June 24, 2017

DrugPatentWatch Database Preview

Methylprednisolone; neomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methylprednisolone; neomycin sulfate and what is the scope of methylprednisolone; neomycin sulfate freedom to operate?

Methylprednisolone; neomycin sulfate
is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for methylprednisolone; neomycin sulfate.

Summary for Generic Name: methylprednisolone; neomycin sulfate

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list39
Clinical Trials: see list1,044
Drug Prices:see low prices
DailyMed Link:methylprednisolone; neomycin sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
NEO-MEDROL
methylprednisolone; neomycin sulfate
OINTMENT;OPHTHALMIC060645-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Express Scripts
Farmers Insurance
McKinsey
Merck
Novartis
AstraZeneca
Citi
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot